Creating delivery devices for injectable drugs has been one of the Challenging task of today. As great number of innovation oriented advancements have occurred in the biologics market, which additionally increases the applicability of the injectable devices in the complex disease areas. The expansion in number of chronic illnesses like diabetes and cancer has increased the requirement for Injectable drugs delivery. Unlike other conventional methods of drug delivery, injectable allow maximum bioavailability of the pharmaceutical drug as it bypasses the first pass metabolism. With considerable development in mechanical headways, the devices being produced and marketed in order to take into account the particular needs of the patients.
How Big is The Global Injectable Drug Delivery Market?
The Global Injectable Drug Delivery Market is expected to be around US$ 1196 Billion by 2028 at a CAGR of 11.5% in the given forecast period.
The major driving factors of Global Injectable Drug Delivery Market are as follows:
The restraining factors of Global Injectable Drug Delivery Market are as follows:
The Global Injectable Drug Delivery Market is segmented on the lines of its usage pattern, formulation packaging, therapeutic application, type, site of administration, distribution channel, facility of use and regional. Based on usage pattern segmentation it covers curative care, immunization and other usage pattern. Based on formulation packaging segmentation it covers ampules, vials, cartridges, bottles. Based on therapeutic application segmentation it covers auto-immune diseases, hormonal disorders, orphan diseases, oncology, and other therapeutic applications. Based on type segmentation it covers devices, formulations. Based on site of administration segmentation it covers skin, circulatory/musculoskeletal, organs, and central nervous system. Based on distribution channel segmentation it covers hospitals, retail pharmacy stores. Based on facility of use segmentation it covers hospitals & clinics, home care settings, other facilities of use. The Global Injectable Drug Delivery Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Injectable Drug Delivery Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Injectable Drug Delivery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Injectable Drug Delivery Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Becton, Dickinson and Company (U.S.), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Injectable Drug Delivery Market has been segmented as below:
By Usage Pattern Analysis:
By Formulation Packaging Analysis:
By Therapeutic Application Analysis:
By Type Analysis:
By Site of Administration Analysis:
By Distribution Channel Analysis:
By Facility of Use Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Injectable Drug Delivery Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Injectable Drug Delivery Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
Epidural Anesthetic Drugs Market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Market Overview
4.2 Injectable Drug Delivery Market, By Facility of Use
4.3 Geographic Analysis: By Site of Administration
4.4 Injectable Drug Delivery Market, By Formulation Packaging
4.5 Geographical Snapshot
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Prevalence of Chronic Diseases
5.2.1.2 Increase in Demand for Self-Injection Devices
5.2.1.3 Growth in the Biologics Market
5.2.1.4 Technological Advancements and New Product Launches
5.2.2 Restraints
5.2.2.1 Infections Associated With Needlestick Injuries
5.2.2.2 Product Recalls
5.2.3 Opportunities
5.2.3.1 Increase in Demand for Biosimilar and Generic Injectables
5.2.3.1.1 Biosimilars
5.2.3.1.2 Generic Injectables
5.2.3.2 Contraceptive Injectables
5.2.4 Challenge
5.2.4.1 Preference for Other Modes of Drug Delivery
6 Regulatory Scenario
6.1 Introduction
6.2 FDA and CE Approvals
6.3 The European Medicines Agency (EMA)
6.4 Clinical Trials
7 Injectable Drug Delivery Market, By Type
7.1 Introduction
7.2 Devices
7.2.1 Conventional Injection Devices
7.2.1.1 By Material
7.2.1.1.1 Glass
7.2.1.1.2 Plastic
7.2.1.2 By Product
7.2.1.2.1 Fillable Syringes
7.2.1.2.2 Prefilled Syringes
7.2.1.3 By Usability
7.2.1.3.1 Reusable Injection Devices
7.2.1.3.2 Disposable Injection Devices
7.2.2 Self-Injection Devices
7.2.2.1 Needle-Free Injectors
7.2.2.1.1 By Product
7.2.2.1.1.1 Fillable Needle-Free Injectors
7.2.2.1.1.2 Prefilled Needle-Free Injectors
7.2.2.1.2 By Technology
7.2.2.1.2.1 Jet-Based Needle-Free Injectors
7.2.2.1.2.2 Spring-Based Needle-Free Injectors
7.2.2.1.2.3 Laser-Powered Needle-Free Injectors
7.2.2.1.2.4 Vibration-Based Needle-Free Injectors
7.2.2.1.3 By Usability
7.2.2.1.3.1 Reusable Needle-Free Injectors
7.2.2.1.3.2 Disposable Needle-Free Injectors
7.2.2.2 Autoinjectors
7.2.2.2.1 By Product
7.2.2.2.1.1 Fillable Autoinjectors
7.2.2.2.1.2 Prefilled Autoinjectors
7.2.2.2.2 By Technology
7.2.2.2.2.1 Automated Autoinjectors
7.2.2.2.2.2 Manual Autoinjectors
7.2.2.2.3 By Design
7.2.2.2.3.1 Standardized Autoinjectors
7.2.2.2.3.2 Customized Autoinjectors
7.2.2.2.4 By Usability
7.2.2.2.4.1 Reusable Autoinjectors
7.2.2.2.4.2 Disposable Autoinjectors
7.2.2.3 Pen Injectors
7.2.2.3.1 By Product
7.2.2.3.1.1 Single-Chambered Pen Injectors
7.2.2.3.1.2 Dual-Chambered Pen Injectors
7.2.2.3.2 By Design
7.2.2.3.2.1 Standard Pen Injectors
7.2.2.3.2.2 Customized Pen Injectors
7.2.2.3.3 By Usability
7.2.2.3.3.1 Reusable Pen Injectors
7.2.2.3.3.2 Disposable Pen Injectors
7.2.2.4 Wearable Injectors
7.2.2.5 Other Devices
7.3 Formulations
7.3.1 Conventional Drug Delivery Formulations
7.3.1.1 Solutions
7.3.1.2 Reconstituted/Lyophilized Formulations
7.3.1.3 Suspensions
7.3.1.4 Emulsions
7.3.2 Novel Drug Delivery Formulations
7.3.2.1 Colloidal Dispersions
7.3.2.1.1 Niosomes
7.3.2.1.2 Liposomes
7.3.2.1.3 Polymeric/Mixed Micelles
7.3.2.1.4 Nanoparticles
7.3.2.1.4.1 Solid-Lipid Nanoparticles
7.3.2.1.4.2 Nanosuspensions
7.3.2.1.4.3 Nanoemulsions
7.3.2.2 Microparticles
7.3.2.2.1 Microspheres
7.3.2.2.2 Microcapsules
7.3.3 Long-Acting Injection Formulations
8 Injectable Drug Delivery Market, By Formulation Packaging
8.1 Introduction
8.2 Ampules
8.3 Vials
8.4 Cartridges
8.5 Bottles
9 Injectable Drug Delivery Market, By Therapeutic Application
9.1 Introduction
9.2 Autoimmune Diseases
9.2.1 Rheumatoid Arthritis
9.2.2 Multiple Sclerosis (MS)
9.2.3 Crohn’s Disease
9.2.4 Psoriasis
9.2.5 Other Autoimmune Diseases
9.3 Hormonal Disorders
9.3.1 Diabetes
9.3.2 Anemia
9.3.3 Reproductive Health Disease
9.3.4 Antithrombotic/Thrombolytic Therapy
9.3.5 Osteoporosis
9.3.6 Growth Hormone Deficiency (GHD)
9.4 Orphan Diseases
9.5 Cancer
9.6 Other Therapeutic Applications
9.6.1 Pain Management
9.6.2 Allergies
9.6.3 Aesthetic Treatment
9.6.4 Hepatitis C
9.6.5 Hemophilia
10 Injectable Drug Delivery Market, By Usage Pattern
10.1 Introduction
10.2 Curative Care
10.3 Immunization
10.4 Others
11 Injectable Drug Delivery Market, By Site of Administration
11.1 Introduction
11.2 Skin (Intradermal and Subcutaneous)
11.3 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
11.4 Organs (Intravitreal and Intra-Articular)
11.5 Central Nervous System (Intracerebral and Intrathecal)
12 Injectable Drug Delivery Market, By Distribution Channel
12.1 Introduction
12.2 Hospitals
12.3 Retail Pharmacy Stores
13 Injectable Drug Delivery Market, By Facility of Use
13.1 Introduction
13.2 Hospitals and Clinics
13.3 Home Care Settings
13.4 Other Facilities of Use
14 Injectable Drug Delivery Market, By Region
14.1 Introduction
14.2 North America
14.2.1 U.S.
14.2.2 Canada
14.3 Europe
14.3.1 Germany
14.3.2 France
14.3.3 U.K.
14.3.4 Italy
14.3.5 Spain
14.3.6 Rest of Europe (RoE)
14.4 Asia
14.4.1 China
14.4.2 Japan
14.4.3 India
14.4.4 Rest of Asia
14.5 Rest of the World (RoW)
15 Competitive Landscape
15.1 Overview
15.2 Market Share Analysis
15.3 Competitive Situation and Trends
15.3.1 Partnerships, Agreements, and Collaborations
15.3.2 Product Launches, Approvals, and Enhancements
15.3.3 Expansions
15.3.4 Acquisitions
16 Company Profiles
16.1 Introduction
16.2 Baxter International, Inc.
16.3 Becton, Dickinson and Company
16.4 Gerresheimer AG
16.5 Pfizer, Inc.
16.6 Schott AG
16.7 ELI Lilly and Company
16.8 Sandoz (A Division of Novartis AG)
16.9 Terumo Corporation
16.10 Teva Pharmaceutical Industries Ltd.
The Global Injectable Drug Delivery Market has been segmented as below:
By Usage Pattern Analysis:
By Formulation Packaging Analysis:
By Therapeutic Application Analysis:
By Type Analysis:
By Site of Administration Analysis:
By Distribution Channel Analysis:
By Facility of Use Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
